Thiazolidine → [5-[3-Chloro-5-(difluoromethoxy)phenyl]-1-(3-pyridyl)pyrazol-3-yl]-thiazolidin-3-yl-methanone
Reaktionsgleichung
[Cl:1][C:2]1[CH:3]=[C:4]([C:12]2[N:16]([C:17]3[CH:18]=[N:19][CH:20]=[CH:21][CH:22]=3)[N:15]=[C:14]([C:23](O)=[O:24])[CH:13]=2)[CH:5]=[C:6]([O:8][CH:9]([F:11])[F:10])[CH:7]=1.[S:26]1[CH2:30][CH2:29][NH:28][CH2:27]1>>[Cl:1][C:2]1[CH:3]=[C:4]([C:12]2[N:16]([C:17]3[CH:18]=[N:19][CH:20]=[CH:21][CH:22]=3)[N:15]=[C:14]([C:23]([N:28]3[CH2:29][CH2:30][S:26][CH2:27]3)=[O:24])[CH:13]=2)[CH:5]=[C:6]([O:8][CH:9]([F:10])[F:11])[CH:7]=1Komponenten
3
Versuchsvorschrift
95 mg (0.26 mmol) of the compound of Example 54A is reacted analogously to the synthesis of the compound of Example 3 with 25 mg (0.28 mmol) of thiazolidine for 30 minutes at room temperature. 65 mg (57% of theory) of the title compound is obtained.
Quellen und Nachweise
- ORD-Eintrag
- ord-3f3b8c72ed9b46dc9b260f0f3aa64cf4
- Quelldatensatz
- uspto-grants-2016_03
- Patentnummer
- US09296720B2
Notizen zur Reaktion
Wird geladen…